1 |
Aoyama H, Tago M, Shirato H, et al (2015). Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: secondary analysis of the JROSG 99-1 randomized clinical Trial. JAMA Oncol, 1, 457-64.
DOI
|
2 |
Chang EL, Wefel JS, Hess KR, et al (2009). Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol, 10, 1037-44.
DOI
|
3 |
Gondi V, Tome WA, Mehta MP et al (2010). Why avoid the hippocampus? A comprehensive review. Radiother Oncol, 97, 370-6.
DOI
|
4 |
Gondi V, Pugh SL, Tome WA, et al (2014). Preservation of memory with conformal avoidance of the hippocampal neural stem cell compartment during whole brain radiotehrapy for brain metastases (RTOG 0933): A phase II multi-institutional trial. J Clin Oncol, 32, 3810-16.
DOI
|
5 |
Marsh JC, Herskovic AM, Gielda BT, et al, (2010). Intracranial metastatic disease spares the limbic circuit. A review of 697 metastatic lesions in 107 patients. Int J Radiat Oncol Biol Phys, 76, 504-12.
DOI
|
6 |
Sahgal A, Aoyama H, Kocher M, et al (2015). Phase 3 trials of Stereotactic Radiosurgery with or without whole brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys, 91, 718-20.
DOI
|